信号转导与靶向治疗（英文）（Signal Transduction and Targeted Therapy） 知网目次万方目次维普目次

期刊简介

《信号转导与靶向治疗》期刊已被查看： 次

更新频次

高频栏目:

RESEARCH HIGHLIGHTS-100%-期平均发文量9篇
REVIEWS-100%-期平均发文量8篇
ARTICLES-100%-期平均发文量14篇
LETTERS-83.3%-期平均发文量7篇

中频栏目:

CORRECTION-33.3%-期平均发文量1篇
CORRECTIONS-33.3%-期平均发文量2篇

低频栏目:

LETTER-16.7%-期平均发文量1篇
RETRACTION-16.7%-期平均发文量1篇

单位占比

一作占比

投稿指南

1、投稿方式：在线投稿。

2、刊内网址（202404期）：

http://www.nature.com/sigtrans/

3、投稿系统：https://mts-sigtrans.nature.com/

4、官网邮箱：sttt@scu.edu.cn

5、官网电话：028-85421753

6、微信公众号：Sigtrans

2024年7月10日星期三

《信号转导与靶向治疗（英文版）》作者指南

【官网信息】

Guide for Authors

Aims and Scope

Signal Transduction and Targeted Therapy is an international, peer-reviewed, open-access journal that publishes original research articles and review articles related to all aspects of signal transduction in physiological and pathological processes, as well as signal transduction-targeted therapeutics in the form of biological agents and small molecular drugs used to treat human diseases such as cancer, cardiovascular diseases, autoimmune diseases, nervous system diseases, and others. This journal focuses on cutting-edge advances both experimentally and clinically.

Journal Details

Editors-in-Chief:

Carlo M. Croce

Institute of Genetics, The Ohio State University, USA

Kang Zhang

Institute for Genomic Medicine, University of California San Diego, USA

Yu-Quan Wei

State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, China

Editorial office:

Address: No. 17, Section 3, Renmin South Road, Chengdu, Sichuan, 610041, China

Tel: 86-28-85421753 Fax: 86-28-85164060

E-mail: sttt@scu.edu.cn

ARTICLE TYPES

……

作者指南更多详情：

https://www.nature.com/documents/sigtrans-gta.pdf

上一篇：中华实验和临床病毒学杂志下一篇：实用器官移植电子杂志